Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001209191-17-027440
Filing Date
2017-04-19
Accepted
2017-04-19 16:08:33
Documents
1
Period of Report
2017-04-17

Document Format Files

Seq Description Document Type Size
1 FORM 4 SUBMISSION doc4.html 4  
1 FORM 4 SUBMISSION doc4.xml 4 3104
  Complete submission text file 0001209191-17-027440.txt   4694
Mailing Address C/O AXOVANT SCIENCES, INC. 320 WEST 37TH STREET NEW YORK NY 10018
Business Address
VERNON W ANTHONY (Reporting) CIK: 0001369091 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-37418 | Film No.: 17770073

Mailing Address CLARENDON HOUSE 2 CHURCH STREET HAMILTON D0 HM11
Business Address CLARENDON HOUSE 2 CHURCH STREET HAMILTON D0 HM11 441-295-5950
Axovant Sciences Ltd. (Issuer) CIK: 0001636050 (see all company filings)

EIN.: 000000000 | State of Incorp.: D0 | Fiscal Year End: 0331
SIC: 2834 Pharmaceutical Preparations